A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.
Auteurs : Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, Langouo Fontsa M Année : 2022 Journal : Diagnostics (Basel)
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.
Auteurs : Langouo Fontsa M, Aiello MM, Migliori E, Scartozzi M, Lambertini M, Willard-Gallo K, Solinas C Année : 2022 Journal : Target Oncol
Biomarkers and immunotherapy: where are we?
Auteurs : Langouo Fontsa M, Padonou F, Willard-Gallo K Année : 2022 Journal : Curr Opin Oncol
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer.
Auteurs : Noël G, Langouo Fontsa M, Willard-Gallo K Année : 2018 Journal : Semin Cancer Biol
An atypical presentation of bronchial adenocarcinoma.
Auteurs : Langouo Fontsa M, CsToth I, Berghmans T, Feoli F, Meert AP Année : 2013 Journal : Rev Med Brux